AML, relapsed/refractory

Clinical trials for AML, relapsed/refractory explained in plain language.

Never miss a new study

Get alerted when new AML, relapsed/refractory trials appear

Sign up with your email to follow new studies for AML, relapsed/refractory, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Not yet recruiting 1

New transplant combo aims to outsmart relapsed leukemia

Disease control Not yet recruiting

This study looks at a stem cell transplant from a half-matched donor (haploidentical) combined with drugs to prevent the cancer from coming back. It includes 40 adults aged 18-65 with active AML that has returned or not responded to treatment. The goal is to see if this approach …

Matched conditions: AML, RELAPSED/REFRACTORY

Sponsor: Union Hospital, Tongji Medical College, Huazhong University of Science and Technology • Aim: Disease control

Last updated Jun 27, 2026 12:31 UTC

AML, relapsed/refractory

Get alerted when new AML, relapsed/refractory trials appear

New transplant combo aims to outsmart relapsed leukemia